Check out Bionano's blog posts to learn more about driving discoveries across multiple applications using OGM, new studies and publications, scientific events, communities, and much more.
Evaluation of OGM in a Variety of Hematological Malignancies Demonstrates High Concordance with Traditional Methods, Time and Cost Advantages, and Potential for Discovery of Novel Therapeutic Targets
Cytogenetic Experts from Top US Institutions Recommend Saphyr be Considered a First-Line Test for Clinically Relevant Detection and Identification of Structural Variations in Leukemias
